Clovis to collaborate with German biotech company

Clovis to collaborate with German biotech company

BOULDER/BERLIN -- Clovis Oncology, Inc. (NASDAQ: CLVS) announced it has entered into a global licensing and collaboration agreement with 3B Pharmaceuticals GmbH (3BP), a private German... Read More

Tuesday September 24, 2019 0 comments Tags: Boulder, Clovis Oncology, 3B Pharmaceuticals, Patrick Mahaffy